Human Genome Epidemiology Literature Finder
Records 1 - 24 (of 24 Records) |
Query Trace: Arthritis and GGH[original query] |
---|
Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis. Pharmacogenetics 2004 Nov 14 (11): 733-9. Dervieux Thierry, Kremer Joel, Lein Diana Orentas, Capps Robert, Barham Robert, Meyer Gary, Smith Katie, Caldwell Jacques, Furst Daniel |
Genetic polymorphism of C452T (T127I) in human gamma-glutamyl hydrolase in a Japanese population. Biological & pharmaceutical bulletin 2007 Apr 30 (4): 839-41. Hayashi Hideki, Fujimaki Chihiro, Inoue Kazuyuki, Suzuki Toshio, Itoh Kunihi |
Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients. Pharmacogenomics 2007 Feb 8 (2): 141-50. van der Straaten R J H M, Wessels Judith A M, de Vries-Bouwstra Jeska K, Goekoop-Ruiterman Yvonne P M, Allaart Cornelia F, Bogaartz Judith, Tiller Marco, Huizinga Tom W J, Guchelaar Henk-J |
Interaction of genes from influx-metabolism-efflux pathway and their influence on methotrexate efficacy in rheumatoid arthritis patients among Indians. Pharmacogenetics and genomics 2008 Dec 18 (12): 1041-9. Sharma Shruti, Das Mitashree, Kumar Ashok, Marwaha Vishal, Shankar Subramanian, Aneja Ritu, Grover Rahul, Arya Vivek, Dhir Varun, Gupta Rajiva, Kumar Uma, Juyal Ramesh C, B K Thel |
Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms. The British journal of dermatology 2009 Feb 160 (2): 438-41. Warren R B, Smith R L, Campalani E, Eyre S, Smith C H, Barker J N W N, Worthington J, Griffiths C E |
Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis. Journal of clinical pharmacy and therapeutics 2009 Jun 34 (3): 355-61. Hayashi H, Fujimaki C, Daimon T, Tsuboi S, Matsuyama T, Itoh |
Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis. Drug metabolism and pharmacokinetics 2012 27 (2): 192-9. Kato Tomomi, Hamada Akinobu, Mori Shunsuke, Saito Hideyu |
Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. British journal of clinical pharmacology 2011 Feb 71 (2): 237-43. Yanagimachi Masakatsu, Naruto Takuya, Hara Takuma, Kikuchi Masako, Hara Ryoki, Miyamae Takako, Imagawa Tomoyuki, Mori Masaaki, Kaneko Tetsuji, Morita Satoshi, Goto Hiroaki, Yokota Shump |
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. The pharmacogenomics journal 2012 Mar . Owen SA, Hider SL, Martin P, Bruce IN, Barton A, Thomson W |
Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis. Clinical and experimental rheumatology 0 32 (3): 324-32. Davis L A, Polk B, Mann A, Wolff R K, Kerr G S, Reimold A M, Cannon G W, Mikuls T R, Caplan |
Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients. Pharmacogenomics 2015 Dec . Moya Patricia, Salazar Juliana, Arranz María Jesús, Díaz-Torné César, Del Río Elisabeth, Casademont Jordi, Corominas Hèctor, Baiget Montserr |
Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis. Pharmacogenomics 2015 Nov . Ghodke-Puranik Yogita, Puranik Amrutesh S, Shintre Pooja, Joshi Kalpana, Patwardhan Bhushan, Lamba Jatinder, Niewold Timothy B, Chopra Arvi |
Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis. Polskie Archiwum Medycyny Wewnetrznej 2015 125 (3): 152-61. ?wierkot Jerzy, ?l?zak Ryszard, Karpi?ski Pawe?, Paw?owska Justyna, Noga Leszek, Szechi?ski Jacek, Wiland Pio |
Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome. Pharmacogenomics 2016 Sep . Lima Aurea, Bernardes Miguel, Azevedo Rita, Seabra Vitor, Medeiros R |
Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis. Journal of pharmaceutical health care and sciences 2016 2 13. Hashiguchi Masayuki, Tsuru Tomomi, Miyawaki Kumika, Suzaki Midori, Hakamata Jun, Shimizu Mikiko, Irie Shin, Mochizuki Mayu |
Sex Differences in mRNA Expression of Reduced Folate Carrier-1, Folypolyformyl Glutamate Synthase, and ?-Glutamyl Hydrolase in a Healthy Japanese Population. Journal of clinical pharmacology 2016 May . Hashiguchi Masayuki, Tanaka Takanori, Shimizu Mikiko, Tsuru Tomomi, Chiyoda Takeshi, Miyawaki Kumika, Irie Shin, Takeuchi Osamu, Hakamata Jun, Mochizuki Mayu |
Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population. Journal of pharmaceutical health care and sciences 2016 2 35. Hashiguchi Masayuki, Shimizu Mikiko, Hakamata Jun, Tsuru Tomomi, Tanaka Takanori, Suzaki Midori, Miyawaki Kumika, Chiyoda Takeshi, Takeuchi Osamu, Hiratsuka Jiro, Irie Shin, Maruyama Junya, Mochizuki Mayu |
Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis. Scientific reports 2016 Oct 6 35615. Yamamoto Tatsuhiro, Shikano Kotaro, Nanki Toshihiro, Kawai Shinic |
Factors Predicting the Therapeutic Response to Methotrexate in Japanese Patients with Rheumatoid Arthritis: A Hospital-Based Cohort Study. Biological & pharmaceutical bulletin 2018 41 (9): 1414-1422. Hakamata Jun, Kaneko Yuko, Shimizu Mikiko, Yamaoka Kunihiro, Maruyama Junya, Takeuchi Tsutomu, Mochizuki Mayumi, Hashiguchi Masayu |
Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients. Clinical rheumatology 2018 Jul . Sandhu Amit, Ahmad Shabeer, Kaur Jasbinder, Bhatnagar Archana, Dhawan Veena, Dhir Var |
Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients. The pharmacogenomics journal 2019 Oct . Muralidharan Niveditha, Sundaram Rajan, Kodidela Sunitha, Chengappa K G, Mariaselvam Christina Mary, Misra Durga P, Negi Vir |
Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis. Journal of clinical medicine 2021 Sep 10 (18): . Escudero-Contreras Alejandro, López-Medina Clementina, Collantes-Estévez Eduardo, Ortega-Castro Rafaela, Calvo-Gutiérrez Jerusalem, Mena-Vázquez Natalia, Panero-Lamothe Blanca, Manzanares-Martín Bárbara, Cáliz-Cáliz Rafael, Jiménez-Morales Alberto, Ruiz-Jiménez Mayte, Font-Ugalde Pil |
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report. Pharmacogenomics and personalized medicine 2022 5 15 465-475. Jeiziner Chiara, Allemann Samuel S, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis. Pharmaceutics 2023 6 15 (6): . Francisco C Ceballos, Eugenio Chamizo-Carmona, Carmen Mata-Martín, Carmen Carrasco-Cubero, Juan J Aznar-Sánchez, Raúl Veroz-González, Sara Rojas-Herrera, Pedro Dorado, Adrián LLere |
- Page last reviewed:Feb 1, 2024
- Content source: